in Newswire October 18, 2016

Class Action Says Mylan Illegally Inflated EpiPen Prices

by Corrado Rizzi

Last Updated on October 18, 2016

Corcoran et al v. Mylan Pharmaceuticals Inc. et al

Filed: October 18, 2016 § 3:16-cv-05983

California and Massachusetts consumers have filed a proposed class action against Mylan claiming the company illegally raised the EpiPen's price by more than 500 percent.


Mylan, Inc.



Last Updated on October 18, 2016 — 11:10 AM

Corrado Rizzi

Corrado Rizzi is the Managing Editor and a writer for

About is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.